Association of Apolipoprotein B/Apolipoprotein A1 Ratio and Coronary Artery Stenosis and Plaques Detected by Multi-Detector Computed Tomography in Healthy Population

다국어 초록 (Multilingual Abstract)

Despite the noninvasiveness and accuracy of multidetector computed tomography (MDCT),its use as a routine screening tool for occult coronary atherosclerosis is unclear. We investigated whether the ratio of apolipoprotein B (apoB) to apolipoprotein A1 (apoA1), an indicator of the balance between atherogenic and atheroprotective cholesterol transport could predict occult coronary atherosclerosis detected by MDCT. We collected the data of 1,401 subjects (877 men and 524 women) who participated in a routine health screening examination of Asan Medical Center. Significant coronary artery stenosis defined as > 50% stenosis was detected in 114 subjects (8.1%). An increase in apoB/A1 quartiles was associated with increased percentages of subjects with significant coronary stenosis and noncalcified plaques (NCAP). After adjustment for confounding variables, each 0.1increase in serum apoB/A1 was significantly associated with increased odds ratios (ORs) for coronary stenosis and NCAP of 1.23 and 1.18, respectively. The optimal apoB/A1 ratio cut off value for MDCT detection of significant coronary stenosis was 0.58, which had a sensitivity of 70.2% and a specificity of 48.2% (area under the curve, 0.61; 95% CI, 0.58-0.63, P < 0.001). Our results indicate that apoB/A1 ratio is a good indicator of occult coronary atherosclerosis detected by coronary MDCT.

참고문헌 (Reference)

1 Enkhmaa B, "Usefulness of apolipoprotein B/apolipoprotein A-I ratio to predict coronary artery disease independent of the metabolic syndrome in African Americans" 106 : 1264-1269, 2010

2 Hacker M, "Sixty-four slice spiral CT angiography does not predict the functional relevance of coronary artery stenoses in patients with stable angina" 34 : 4-10, 2007

3 Schuijf JD, "Relationship between noninvasive coronary angiography with multi-slice computed tomography and myocardial perfusion imaging" 48 : 2508-2514, 2006

4 Agatston AS, "Quantification of coronary artery calcium using ultrafast computed tomography" 15 : 827-832, 1990

5 Noma A, "Plasma lipids and apolipoproteins as discriminators for presence and severity of angiographically defined coronary artery disease" 49 : 1-7, 1983

6 Hoffmann U, "Noninvasive assessment of plaque morphology and composition in culprit and stable lesions in acute coronary syndrome and stable lesions in stable angina by multidetector computed tomography" 47 : 1655-1662, 2006

7 Marcovina S, "Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels" 259 : 437-446, 2006

8 Seidel D, "Lipoproteins in liver disease" 25 : 541-551, 1987

9 Kinlay S, "Lipid and apolipoprotein levels in an Australian community" 154 : 170-175, 1991

10 Peppa M, "Lipid abnormalities and cardiometabolic risk in patients with overt and subclinical thyroid disease" 2011 : 575840-, 2011

11 Schuijf JD, "Invasive versus noninvasive evaluation of coronary artery disease" 1 : 190-199, 2008

12 Fujii K, "Intravascular ultrasound assessment of ulcerated ruptured plaques: a comparison of culprit and nonculprit lesions of patients with acute coronary syndromes and lesions in patients without acute coronary syndromes" 108 : 2473-2478, 2003

13 Marcovina SM, "International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B: IV. comparability of apolipoprotein B values by use of International Reference Material" 40 : 586-592, 1994

14 Thaulow E, "Initial clinical presentation of cardiac disease in asymptomatic men with silent myocardial ischemia and angiographically documented coronary artery disease (the Oslo Ischemia Study)" 72 : 629-633, 1993

15 Walldius G, "High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study" 358 : 2026-2033, 2001

16 Badimon JJ, "Genesis and dynamics of atherosclerotic lesions: implications for early detection" 27 : 38-47, 2009

17 "Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)" 285 : 2486-2497, 2001

18 Yusuf S, "Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART Study): case-control study" 364 : 937-952, 2004

19 Vanhoenacker PK, "Diagnostic performance of multidetector CT angiography for assessment of coronary artery disease: meta-analysis" 244 : 419-428, 2007

20 Foster G, "Detection of noncalcified and mixed plaque by multirow detector computed tomography" 7 : 57-64, 2009

21 Waxman S, "Detection and treatment of vulnerable plaques and vulnerable patients: novel approaches to prevention of coronary events" 114 : 2390-2411, 2006

22 Achenbach S, "Current role of cardiac computed tomography" 32 : 97-107, 2007

23 Choi EK, "Coronary computed tomography angiography as a screening tool for the detection of occult coronary artery disease in asymptomatic individuals" 52 : 357-365, 2008

24 Rumberger JA, "Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area: a histopathologic correlative study" 92 : 2157-2162, 1995

25 Pilote L, "Clinical yield and cost of exercise treadmill testing to screen for coronary artery disease in asymptomatic adults" 81 : 219-224, 1998

26 Holmes DR Jr, "Association of risk factor variables and coronary artery disease documented with angiography" 63 : 293-299, 1981

27 Nam HJ, "Association between brachial-ankle pulse wave velocity and occult coronary artery disease detected by multi-detector computed tomography" 157 : 227-232, 2012

28 Budoff MJ, "Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology" 114 : 1761-1791, 2006

29 Reinhart RA, "Apolipoproteins A-I and B as predictors of angiographically defined coronary artery disease" 150 : 1629-1633, 1990

30 Batista MC, "Apolipoprotein A-I, B-100, and B-48 metabolism in subjects with chronic kidney disease, obesity, and the metabolic syndrome" 53 : 1255-1261, 2004

31 Leber AW, "Accuracy of 64-slice computed tomography to classify and quantify plaque volumes in the proximal coronary system: a comparative study using intravascular ultrasound" 47 : 672-677, 2006

32 Austen WG, "A reporting system on patients evaluated for coronary artery disease: report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association" 51 : 5-40, 1975

33 Stary HC, "A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association" 92 : 1355-1374, 1995